Update:
Dan started his second round of chemo today and is, overall, feeling good! We are so grateful for your continued prayers and support, and feel incredibly blessed by the amazing people surrounding us. We thank God daily for how He has prepared us for this trial.
Molecular profiling testing has identified some targets that may be used in future treatments. While pancreatic cancer remains the most likely diagnosis, the primary site has not been definitively confirmed (meaning there remains inconclusive evidence of the location of a primary tumor that produced the widespread lymph node metastases). We are still actively trying to acquire more data to further delineate the origin. Encouragingly, the tumor marker associated with pancreatic cancer has decreased significantly since Dan began chemo. Additionally, the pain that was the first sign of his cancer is also significantly reduced. These are both great signs that his cancer may be chemosensitive.
We are deeply thankful for our medical team—which continues to grow and often includes those we are honored to call close friends. We’re praying for continued wisdom and clarity as they navigate this complex and challenging case.
Thank you again for your unwavering support—the time you’ve given, the cards, messages, phone calls, meals, rides, gift cards, generous donations, smiles, hugs, and love. Each gesture means more than we can say.
